Method of detecting cancer using delta-catenin
AssigneeEast Carolina University
InventorsQun Lu, Yan-hua Chen
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for detecting or screening for the presence of cancer in a subject. The method comprises obtaining, providing or collecting a tissue or fluid sample (such as a urine sample) from said subject, and then determining the presence or absence of delta-catenin in said sample, or increased levels of delta-catenin in said sample as compared to a normal or control subject. The presence of delta-catentin in said sample, or increased levels of delta-ctanin in said sample, indicating said subject is afflicted with or at least at risk of developing cancer.
Claims20
A method for detecting cancer in a subject comprising the steps of:
- obtaining a body fluid sample from said subject, and
- determining the presence or absence of delta-catenin in said body fluid sample,
- the presence of delta-catentin in said body fluid sample indicating said subject is afflicted with or at least at risk of developing cancer.
In a method for detecting cancer in a subject by detecting the presence of a cadherin, prostate specific antigen, and/or p120 cancer biomarker in said subject, the improvement comprising the steps of:
- obtaining a body fluid sample from said subject, and
- determining the presence or absence of delta-catenin in said body fluid sample,
- the presence of delta-catentin in said body fluid sample further indicating said subject is afflicted with or at least at risk of developing cancer.
Dependencies are inferred from the claim text.